UPDATE 1-European biotech firm BioNTech reverses course in early trading
Oct 10 – Shares of BioNTech SE tumbled nearly 12%
in afternoon trade, erasing all its gains from earlier on
Thursday, another sign of weakness in the IPO market after the
collapse of WeWork’s market debut.
in afternoon trade, erasing all its gains from earlier on
Thursday, another sign of weakness in the IPO market after the
collapse of WeWork’s market debut.
Posted by Reuters
